XHKG8513
Market cap18mUSD
Dec 23, Last price
0.18HKD
1D
-5.76%
1Q
-14.69%
IPO
-78.57%
Name
IAG Holdings Ltd
Chart & Performance
Profile
IAG Holdings Limited is an investment holding company mainly engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices. It also provides tooling services. Molded plastic parts include component parts, as well as assembly of plastic parts assembled into sub-assembly products. The injection molded plastic parts are made for a range of medical uses such as respiratory products, dialysis products, blood bag products, drug delivery products and diagnostic tools. Tooling services are the services provided for the fabrication of mold to be used in the injection molding process. The major consumers include multinational corporation (MNC) medical device companies from the United States, Europe and Japan.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 9,148 -37.58% | 14,656 -25.88% | 19,773 -16.86% | ||||||
Cost of revenue | 12,780 | 17,717 | 19,717 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (3,632) | (3,061) | 56 | ||||||
NOPBT Margin | 0.28% | ||||||||
Operating Taxes | (74) | 101 | 161 | ||||||
Tax Rate | 287.50% | ||||||||
NOPAT | (3,558) | (3,162) | (105) | ||||||
Net income | (6,747) 120.27% | (3,063) -59.38% | (7,540) -1,061.73% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 964 | 1,622 | |||||||
BB yield | -2.48% | -3.80% | |||||||
Debt | |||||||||
Debt current | 2,683 | 1,661 | 2,180 | ||||||
Long-term debt | 4,499 | 3,220 | 4,386 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | 1,067 | 1,180 | 1,427 | ||||||
Net debt | 4,442 | 1,555 | 1,492 | ||||||
Cash flow | |||||||||
Cash from operating activities | (1,185) | (582) | 3,157 | ||||||
CAPEX | (61) | (792) | (240) | ||||||
Cash from investing activities | 3 | (751) | (365) | ||||||
Cash from financing activities | 509 | (474) | (3,194) | ||||||
FCF | (69) | (3,279) | (130) | ||||||
Balance | |||||||||
Cash | 1,598 | 3,660 | 4,078 | ||||||
Long term investments | 1,142 | (334) | 996 | ||||||
Excess cash | 2,283 | 2,593 | 4,085 | ||||||
Stockholders' equity | (19,310) | (9,165) | (6,081) | ||||||
Invested Capital | 27,486 | 22,005 | 21,518 | ||||||
ROIC | |||||||||
ROCE | 0.36% | ||||||||
EV | |||||||||
Common stock shares outstanding | 571,486 | 526,531 | 463,095 | ||||||
Price | 0.07 -16.05% | 0.08 -79.23% | 0.39 -32.76% | ||||||
Market cap | 38,861 -8.88% | 42,649 -76.39% | 180,607 -35.07% | ||||||
EV | 43,288 | 44,682 | 182,748 | ||||||
EBITDA | (1,434) | (1,036) | 2,561 | ||||||
EV/EBITDA | 71.36 | ||||||||
Interest | 159 | 145 | 241 | ||||||
Interest/NOPBT | 430.36% |